BETHLEHEM, Pa., Aug. 29, 2019 (GLOBE NEWSWIRE) — B. Braun Interventional Systems Inc. (BIS), a company dedicated to providing innovative solutions in the field of congenital and structural interventional cardiology, today announced it has signed an exclusive U.S. distribution agreement with Nano4imaging for their EmeryGlide™ guidewire. The EmeryGlide MR conditional […]
Other News
Concept Medical Inc. Granted ‘Breakthrough Device Designation’ From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon
TAMPA, Fla.–(BUSINESS WIRE)–Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of stenotic lesions of Arteriovenous Fistulae or Arteriovenous graft in hemodialysis treatment of renal failure. The FDA received Concept […]
Medtronic EVP & CVG President Mike Coyle to Speak at Wells Fargo Securities Healthcare Conference
DUBLIN, Aug. 29, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 14th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 5, 2019, in Boston. Mike Coyle, executive vice president and president of the Cardiac and Vascular Group (CVG) […]
LindaCare Partners with Philips
LindaCare’s OnePulse combines with Philips’ IntelliSpace Cardiovascular informatics platform to streamline in-hospital and remote follow-up care for patients with cardiac implantable electronic devices LEUVEN, Belgium and STAMFORD, Conn., Aug. 29, 2019 /PRNewswire/ — Prior to the European Society of Cardiology (ESC) Congress 2019 (Paris, France, August 31 – September 4), LindaCare announced that it is collaborating with Philips to combine LindaCare’s innovative […]
Samsung Collaboration with Kaiser Permanente Delivers Improvements in Home-Based Cardiac Rehabilitation
The home-based cardiac rehabilitation program experienced just 2 percent readmission rates and saw a 74 percent improvement in completion rates compared to clinic-based programs Samsung Electronics revealed the results of a joint cardiac rehabilitation initiative, developed in collaboration with Kaiser Permanente, the largest not-for-profit integrated health system in America. Samsung […]
Surmodics Completes Enrollment in Pivotal TRANSCEND Clinical Trial
Study designed to evaluate safety, efficacy of the company’s next-generation SurVeil™ drug-coated balloon Company Raises 2019 Revenue and EPS Guidance EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced it has completed enrollment in TRANSCEND, […]
FDA Grants Fast Track Designation for Farxiga in Chronic Kidney Disease
AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to delay the progression of renal failure and prevent cardiovascular (CV) and renal death in patients with chronic kidney disease (CKD). The FDA’s Fast Track program is designed […]
Cardiology Compensation Continues to Rise; First Heart Failure Compensation Data Reported
MedAxiom New Survey of 2,300 physicians reveals impactful health care industry trends NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, an American College of Cardiology Company, the nation’s leading cardiovascular health care performance community and top cardiovascular-specific consulting firm, has released its seventh annual. The report reveals trends that help cardiovascular organizations navigate an […]
Orchestra BioMed™ Appoints Dennis Donohoe, M.D., Leading Clinical Development Expert, as Chief Medical Officer
Dr. Donohoe brings nearly 30 years of successful clinical and regulatory experience advancing medical devices in the cardiology and endovascular space NEW HOPE, Pa., Aug. 27, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in […]
Avinger Closes $4.5 Million Equity Offering
REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten public offering of 3,813,559 shares of its common stock at a price of $1.18 per share, for total gross proceeds […]



